نتائج البحث 551-560 من 3721 لعملية البحث عن anti-TNF drugs
... Anti-PD-1/L1 in Patients with Locally Advanced or ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... treatment until disease ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...
Treatment for FSGS is considered unsuccessful if the patient is unresponsive to standard therapy (e.g., at least 8 weeks of corticosteroids) and fails to ...
ADPKD is a leading cause of end-stage renal disease. Recently, a new medication called Tolvaptan has been approved by the FDA to slow progression of ADPKD.
A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the ...
العلاج. Treatment for hepatocellular carcinoma depends on the location and the extent of the cancer. Treatment also may depend on the condition of the liver.
PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS. Rochester, Minn. The purpose of this ...
Monoclonal antibodies, such as inotuzumab ozogamicin, may block cancer growth in different ways by targeting certain cells. Drugs used in chemotherapy work in ...
Proton therapy, Radiation therapy, Intensity-modulated radiation therapy, Intraoperative radiation therapy, Stereotacti...c body radiotherapy, Colon cancer ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.